Čeština 
Slovenčina 
Română 
Deutsch RAVATA
Substitution treatment for opioid drug dependence within a framework of medical, social and psychological treatment.
QUALITATIVE AND QUANTITATIVE COMPOSITION
- Ravata 2 mg: One sublingual tablet contains buprenorphine 2 mg (as buprenorphine hydrochloride 2.16 mg).
Excipient with known effect: Lactose monohydrate 20 mg.
- Ravata 8 mg: Each sublingual tablet contains 8 mg buprenorphine (as buprenorphine hydrochloride 8.64 mg).
Excipient with known effect: Lactose monohydrate 80 mg
THERAPEUTIC INDICATIONS
Used for substitution treatment for opioid dependence in the specialized medical, social and psychological care.
DISPENSING AND REIMBURSEMENT
Medicinal product is subjected to medical prescription. The medicinal product is not covered by public health insurance.
Mandatory information
